Literature DB >> 17120470

Determining disease severity in severe sepsis and septic shock.

Michael W Donnino1, Jonathan Fisher, Jonathan Fischer.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17120470     DOI： 10.1007/bf02934742

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  12 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Recognising clinical instability in hospital patients before cardiac arrest or unplanned admission to intensive care. A pilot study in a tertiary-care hospital.

Authors:  M D Buist; E Jarmolowski; P R Burton; S A Bernard; B P Waxman; J Anderson
Journal:  Med J Aust       Date:  1999-07-05       Impact factor: 7.738

3.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule.

Authors:  Nathan I Shapiro; Richard E Wolfe; Richard B Moore; Eric Smith; Elizabeth Burdick; David W Bates
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

5.  Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock.

Authors:  J Bakker; M Coffernils; M Leon; P Gris; J L Vincent
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

6.  Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

Authors:  Edward Abraham; Pierre-François Laterre; Rekha Garg; Howard Levy; Deepak Talwar; Benjamin L Trzaskoma; Bruno François; Jeffrey S Guy; Martina Brückmann; Alvaro Rea-Neto; Rolf Rossaint; Dominique Perrotin; Armin Sablotzki; Nancy Arkins; Barbara G Utterback; William L Macias
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

7.  Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: preliminary study.

Authors:  Michael D Buist; Gaye E Moore; Stephen A Bernard; Bruce P Waxman; Jeremy N Anderson; Tuan V Nguyen
Journal:  BMJ       Date:  2002-02-16

8.  Prognostic indexes of septic syndrome in the emergency department.

Authors:  Giuseppe Giannazzo; Francesco Tola; Simone Vanni; Ernesta Bondi; Giuseppe Pepe; Stefano Grifoni
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

9.  The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock.

Authors:  I Salvo; W de Cian; M Musicco; M Langer; R Piadena; A Wolfler; C Montani; E Magni
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

Review 10.  Reducing mortality in sepsis: new directions.

Authors:  Jean-Louis Vincent; Edward Abraham; Djillali Annane; Gordon Bernard; Emanuel Rivers; Greet Van den Berghe
Journal:  Crit Care       Date:  2002-12-05       Impact factor: 9.097
View more
  2 in total

Review 1.  SIRS or qSOFA? Is that the question? Clinical and methodological observations from a meta-analysis and critical review on the prognostication of patients with suspected sepsis outside the ICU.

Authors:  Stefano Franchini; Luca Scarallo; Michele Carlucci; Luca Cabrini; Moreno Tresoldi
Journal:  Intern Emerg Med       Date:  2018-10-15       Impact factor: 3.397

2.  Severe sepsis and septic shock in pre-hospital emergency medicine: survey results of medical directors of emergency medical services concerning antibiotics, blood cultures and algorithms.

Authors:  Sebastian Casu; David Häske
Journal:  Intern Emerg Med       Date:  2015-12-30       Impact factor: 3.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.